CD19 and dermatomyositis: Interestingly, one patient with amyopathic dermatomyositis showed CD3–CD19– cells expressing AIRE in the peripheral blood before the treatment but not during the remission phase, suggesting a novel link between organ‐specific autoimmunity and dysregulated AIRE expression also in clinical settings.